ThomasP. J., “BSE/CJD: the need for statistics”, letter to Lord Wade, 2 April 1996. Copy supplied to the BSE Inquiry and held there in “Bundles” in December 1998.
5.
ThomasP.NewbyM.“Estimating the size of the outbreak of new-variant CJD”, British Food Journal, Vol. 101, No. 1, 44–58 No. 1, 1999.
6.
ThomasP. J.NewbyM. J.ZwisslerR., “New predictions for vCJD numbers”, British Food Journal, Vol. 105, No. 7, 420–433, 2003.
7.
FleetwoodA., Witness Statement 127, The BSE Inquiry, www.bse.org.uk2000.
8.
FleetwoodA., Testimony to the BSE Inquiry, Day 55, pp 89–93, The BSE Inquiry, www.bse.org.uk, 2000.
9.
NewbyM. J.ThomasP. J., “Ranking the preventative measures for new-variant CJD using data on human deaths to the end of 1998”, Witness Statement 313A, The BSE Inquiry, www.bse.org.uk, 2000.
10.
HallbergO., “Estimating human BSE numbers”, oerjan.hallberg@swipnet.se, 1996.
11.
SneathP. H. A., “Statement of P. H. A. Sneath, Emeritus Professor of Microbiology, University of Leicester”, Witness Statement 606, The BSE Inquiry, www.bse.org.uk, 2000.
12.
CousensS. N.VynnyckyE.ZeidlerM.WillR. G.SmithP. G., “Predicting the CJD epidemic in humans”, Nature, Vol. 385 pp 197–198, 16 January 1997.
13.
GhaniA. C.FergusonN. M.DonnellyC. A.HagenaarsT. J.AndersonR. M., “Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain”, Proc. R. Soc. Lond.B265, pp 2443–2452, 1998.
14.
FergusonN. M.DonnellyC. A.GhaniA. C.AndersonR. M., “Predicting the size of the epidemic of the new variant of Creutzfeldt-Jakob disease”, British Food Journal, Vol. 101, No. 2, 86–98, 1999.
15.
GhaniA. C.FergusonN. M.DonnellyC. A.AndersonR. M., “Predicted vCJD mortality in Great Britain”, Nature, Vol. 406, 10 August 2000 pp. 583–584, 2000.
16.
Interview with Prof. Peter Smith, Chairman of SEAC, and Prof. Roy Anderson, member of SEAC, The Daily Telegraph, 25 May 2001.
17.
AndersonR., “The potential human threat”, The Journal of the Foundation for Science and Technology, June, pp 13–16, 2001.
18.
SmithP. G., “Predictions about the future course of the variant CJD epidemic”, Witness Statement 583, The BSE Inquiry, www.bse.org.uk, 2000.
19.
ThomasP. J.NewbyM. J., “Response to WS583 from Professor P. G. Smith entitled ‘Predictions about the future course of the variant CJD epidemic’ ”, Witness Statement 313B, The BSE Inquiry, www.bse.org.uk, 2000.
20.
ThomasP. J.NewbyM. J., “Reply to ‘Predicting the size of the epidemic of the new variant of Creutzfeldt-Jakob disease’”, British Food Journal, Vol. 101, Nos. 3 & 4, 284–288, 1999.
ValleronA.-J.BoelleP.-Y.WillR.CesbronJ.-Y, “Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom”, Science, Vol. 294, pp. 1726–1728, 23 November 2001.
23.
SmithP., Interview on Farming Today, BBC Radio 4, 11 October 2002.
24.
GhaniA. C.DonnellyC. A.FergusonN. M.AndersonR. M., “Updated projections of future vCJD deaths in the UK”, BioMedCentral Infectious Diseases, http://www.biomedcentral.com/1471–2334/3/4, 27 April 2003.
25.
NewbyM. J.ThomasP. J., “Rational assessment of risk predictions: the lessons of BSE and vCJD”, House of Lords, Session 2002–2003, Select Committee on Science and Technology, Fighting Infection, Written Evidence received up to 18 February 2003, HL Paper 23, The House of Lords, London–The Stationery Office Limited, pp 114–118, July 2003.
26.
ThomasP.NewbyM., “Experience with statistical prediction of vCJD numbers”, Submission to the Royal Society working group on best practice in communicating the results of new scientific research to the public, 25 September 2003. Also contained in Thomas, P., “Contribution to Science and Engineering”, DSc Thesis, Vol. 1, paper 47, City University, London, July 2004.
27.
WillR. G., “A new variant of Creutzfeldt-Jakob disease in the UK”, The Lancet, Vol. 347, pp 921–5, 1996.
28.
Lord Wade of Chorlton, Parliamentary Debates (Hansard), House of Lords Official Report, HMSO, Vol. 571, No. 76, 17 April, pp. 695–6, 1996.